Halios, Neneta B.
HRN: 08-50-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2026
07/27/2026
IV
2.25g
Q6
Urosepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes